salvin has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cota-Gomez, A; Gao, B; Hybertson, BM; McCord, JM | 1 |
1 review(s) available for salvin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Nrf2 activator PB125® as a carnosic acid-based therapeutic agent against respiratory viral diseases, including COVID-19.
Topics: Abietanes; Aged; COVID-19; Humans; NF-E2-Related Factor 2; SARS-CoV-2 | 2021 |